SCHEMBL21736055

SCHEMBL21736055

c1ccc(-c2ccc3oc4nc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)nc(-n5c6ccccc6c6cc7ccccc7cc65)c4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.34
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
PTGER4 P35408 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
TBK1 Q9UHD2 1/20 0.32
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21736240 0.95 SIRT2 (0.32) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL21736293 0.93 SMN1; SMN2 (0.38) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL21736065 0.93 TBK1 (0.34) SMN1; SMN2LMNAL3MBTL1KDM4EALDH1A1
SCHEMBL21736008 0.90 SMN1; SMN2 (0.32) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL20670060 0.89 SMN1; SMN2 (0.38) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL16905839 0.88 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL21735869 0.87 TSHR (0.33) SMN1; SMN2LMNAKDM4ENPSR1ALDH1A1
SCHEMBL24772668 0.86 CHEK2 (0.37) SMN1; SMN2LMNAL3MBTL1KDM4EALDH1A1
SCHEMBL21736073 0.85 ALDH1A1 (0.34) SMN1; SMN2L3MBTL1KDM4EATMALDH1A1
SCHEMBL21735860 0.85 TSHR (0.37) SMN1; SMN2LMNAL3MBTL1KDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11530225-B2 Compound and organic light-emitting diode comprising same LG CHEM, LTD. (KR) 2022-12-20 US disclosed
EP-3553049-B1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME LG CHEMICAL LTD (KR) 2022-01-19 EP disclosed
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530225-B2 Compound and organic light-emitting diode comprising same CRY1, CRY2, TRPA1 SMN1; SMN2 1814/4885LMNA 3949/4885L3MBTL1 433/4885
US-20200055865-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME CRY1, CRY2, TRPA1 SMN1; SMN2 1814/4885LMNA 3949/4885L3MBTL1 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.